Karyopharm Therapeutics, Inc. KPTI 深 沪
等待开盘 07-23 09:30:00 美东时间
7.18
-0.685
-8.71%
华盛通- 最 高8.02
- 今 开7.92
- 成交量 71.36万股
- 最 低 7.05
- 昨 收 7.865
- 总市值 1.63亿
- 52周最高 10.99
- 市盈率 静 --
- 换手率 3.15%
- 52周最低 3.6503
- 委 比 -50.17%
- 总股本 2266.29万
- 历史最高 735.075
- 量 比 0.89
- 振 幅 12.33%
- 历史最低 5.00
- 每 手 1
- 风险率 1.67%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Karyopharm drops 21% following disclosure of executive cash retention plan
Karyopharm Pharmaceuticals (KPTI) closed Monday down ~21% after disclosing a "2026 Leadership Cash Retention Program" for some of its top executives. Those who will benefit from it are its CEO, CFO, c...
07-21 04:57
Karyopharm Launches 2026 Executive Retention Incentive Program
Karyopharm Therapeutics ( ($KPTI) ) has issued an update. On July 13, 2026, Kar...
07-18 11:32
Dyne Therapeutics Appoints Barry Greene to Board of Directors
Dyne Therapeutics announced the appointment of Barry Greene to its Board of Directors. With over three decades of experience in the biopharmaceutical industry, Greene brings a proven track record of building and scaling innovative companies across rare diseases, neuroscience, and oncology. His leadership includes roles at Sage Therapeutics and Alnylam Pharmaceuticals, where he contributed to the development and commercialization of novel therapie...
06-22 20:10
Karyopharm posts Phase 3 SENTRY trial presentation on selinexor plus ruxolitinib in myelofibrosis
Karyopharm posts Phase 3 SENTRY trial presentation on selinexor plus ruxolitinib in myelofibrosis Karyopharm published Phase 3 SENTRY trial results evaluating selinexor with ruxolitinib in JAK inhibitor-naïve myelofibrosis. Combination delivered rapid, deeper, sustained spleen volume reduction versu
06-14 16:14
Karyopharm将邀专家解读骨髓纤维化III期SENTRY试验结果
Karyopharm Therapeutics Inc．今日宣布，将于美国东部时间6月2日下午2：00召开投资者电话会议，详细解读selinexor联合r...
06-01 22:44
Karyopharm Expands Equity Incentives and Launches PSU Program
An update from Karyopharm Therapeutics ( ($KPTI) ) is now available. At its May...
05-29 04:27
Karyopharm management participates in Jefferies Global Healthcare Conference fireside chat
Karyopharm management participates in Jefferies Global Healthcare Conference fireside chat Karyopharm will take part in the 2026 Jefferies Global Healthcare Conference on June 4, 2026. Senior management is scheduled for a fireside chat at 8:10 a.m. ET in New York. Disclaimer: This news brief was cre
05-28 19:31
Karyopharm Therapeutics shares are trading lower. The company reported its Q1 financial results.
Karyopharm Therapeutics shares are trading lower. The company reported its Q1 f...
05-15 23:52
Karyopharm Earnings Call: Trial Wins, Cash Questions
Karyopharm Therapeutics INC (($KPTI)) has held its Q1 earnings call. Read on fo...
05-15 08:20
Karyopharm Therapeutics Reports Q1 2026 Results: Full Earnings Call Transcript
Karyopharm Therapeutics (NASDAQ:KPTI) released first-quarter financial results ...
05-14 21:37
